(Q48911058)

16 February 2018

title

Naltrexone-induced opiate receptor supersensitivity (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

18 September 2023

0 references

J. R. Sugarman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289965

18 September 2023

R. S. Zukin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289965

18 September 2023

M. L. Fitz-Syage

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289965

18 September 2023

E. L. Gardner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289965

18 September 2023

S. R. Zukin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289965

18 September 2023

A. R. Gintzler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6289965

18 September 2023

language of work or name

English

0 references

publication date

1 August 1982

1 reference

16 February 2018

12 August 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6289965

full work available at URL

18 September 2023

https://api.elsevier.com/content/article/PII:0006899382908113?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

https://api.elsevier.com/content/article/PII:0006899382908113?httpAccept=text/plain

18 September 2023

1 reference

Crossref

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

18 September 2023

1 reference

16 February 2018

volume

245

1 reference

16 February 2018

issue

1 reference

16 February 2018

page(s)

285-292

1 reference

16 February 2018

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

cites work

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Binding of 3H-naloxone in the mouse brain: effect of ions and tolerance development

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Chronic naloxone results in prolonged increases in opiate binding sites in brain

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Protein measurement with the Folin phenol reagent

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Opiate receptor binding--enhancement by opiate administration in vivo

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Studies of EN-1639A (Naltrexone): A New Narcotic Antagonist

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholamines

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Supersensitivity to opioids following the chronic blockade of endorphin action by naloxone

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Multiple Neurotransmitter Receptors

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Enhanced analgesic effects of morphine after chronic administration of naloxone in the rat

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Muscarinic cholinergic binding in rat brain

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

GTP modulation of opiate receptors in regions of rat brain and possible mechanism of GTP action

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

Multiple opiate receptors: emerging concepts

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(82)90811-3

18 September 2023

Identifiers

1 reference

16 February 2018

1 reference

16 February 2018